Azithromycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70860-125

2 FDA label images from Athenex Pharmaceutical Division, Llc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Azithromycin (NDC 70860-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Athenex Pharmaceutical Division, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Azi04 0002 01)

Structural Formula (Azi04 0002 01)
Chemical structure diagram of azithromycin monohydrate, the active ingredient in Azithromycin injection powder for solution by Athenex Pharmaceutical Division, LLC.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Azi04 0002 02)

Package Label – Principal Display Panel – Vial Label (Azi04 0002 02)
Label for Azithromycin injection, USP, 500 mg per vial, single-dose vial for intravenous infusion only. The label states 'Rx ONLY' and provides NDC 70860-125-41. The label includes the brand name Novaplus and indicates the product is sterile, nonpyrogenic, preservative-free, and includes directions for use and storage. The labeler is Athenex Pharmaceutical Division, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.